Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide vs Diquafosol-Cyclosporine for Perioperative Dry Eye in Cataract Surgery
NCT07397936Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Aug 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rebamipide ophthalmic solution in dry eye disease (DED), sponsored by Samsung Medical Center. Started Aug 2025; status: completed.
02
Drugs
rebamipide ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07397936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397936.